In Vivo Adenovirus-Mediated Gene Transfer of the Escherichia coli Cytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

Human Gene Therapy

Volumn 6, Issue 8, 1995, Pages 1055-1063

  Hirschowitz, Edward A ^a   Ohwada, Akihiko ^a   Pascal, William R ^a   Russi, Thomas J ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSINE DEAMINASE; FLUCYTOSINE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOMA CELL; CELL CONTACT; CELL GROWTH; CHEMOSENSITIVITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA SYNTHESIS INHIBITION; DOSE RESPONSE; ESCHERICHIA COLI; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PROMOTER REGION; TIME;

ADENOVIRIDAE; ANIMAL; ANTINEOPLASTIC AGENTS; BETA-GALACTOSIDASE; CELL DIVISION; CELL LINE; COLONIC NEOPLASMS; ESCHERICHIA COLI; FLUCYTOSINE; FLUOROURACIL; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HT29 CELLS; HUMAN; MICE; MICE, NUDE; NUCLEOSIDE DEAMINASES; PRODRUGS;

ADENOVIRIDAE; ANIMALIA; CYTOMEGALOVIRUS; ESCHERICHIA COLI; MUS MUSCULUS;

EID: 0028795075     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.1995.6.8-1055     Document Type: Article

References (45)

1. AKLI, S., CAILLAUD, C., VIGNE, E., STRATFORD-PERRI-CAUDET, L.D., POENARU, L., PERRICAUDET, M., KAHAN, A., and PESCHANSKI, M.R. (1993). Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genetics 3, 224-228.
2. ANDERSEN, L., KILSTRUP, M., and NEUHARD, J. (1989). Pyrimidine, purine and nitrogen control of cytosine deaminase synthesis in Escherichia coli K12. Involvement of the glnG and purR genes in the regulation of codA expression. Arch. Microbiol. 152, 115-118.
3. AMERICAN HOSPITAL FORMULARY SERVICE [AHFS]. (1994). 5-fluorcytosine. In Drug Information (American Society of Hospital Pharmacists, Bethesda) pp. 81–83.
4. AUSTIN, E.A., and HUBER, B.E. (1992). A fu-st step in development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol. Pharmacol. 43, 380-387.
5. BAJOCCHI, G., FELDMAN, S., CRYSTAL, R.G., and MAS-TRANGELI, A. (1993). Direct in vivo gene transfer to the central nervous system using replication deficient, recombinant adenoviral vectors. Nature Genet. 3, 229-234.
6. BENNETT, J. (1990). Antifungal agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. A.G. Gilman, T. Rail, A.S. Nies, and P. Taylor, eds. (Pergamon Press, New York) pp. 1165–1181.
7. BORRELLI, E., HEYMAN, R., HSI, M., and EVANS, R.M. (1988). Targeting of an inducible toxic phenotype in animal cells. Proc. Natl. Acad. Sci. USA 85, 7572-7576.
8. CALABRESI, P., and CHABNER, B.A. (1990). Antineoplastic agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. A.G. Gilman, T. Rail, A.S. Nies, and P. Taylor, eds. (Pergamon Press, New York) pp. 1209–1263.
9. CHEN, S-H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G., and WOO, S.L.C. (1994). Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA. 91, 3054-3057.
10. CHEN, L., and WAXMAN, D.J. (1995). Intrammoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy. Cancer Res. 55, 581-589.
11. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHH, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
12. DAVIDSON, B., ALLEN, E.D., KOZARSKY, K.F., WILSON, J.M., and ROESSLER, B.J. (1993). A model system for in vivo gene transfer into central nervous system using an adenoviral vector. Nature Genet. 3, 219-223.
13. DIMAIO, J.M., CLARY, B.M., VIA, D.F., COVENEY, E., PAPPAS, T.N., and LYERLY, K.H. (1994). Direct enzyme pro-drug gene therapy for pancreatic cancer in vivo. Surgery 64, 205-213.
14. EZZEDDINE, Z.D., MARTUZA, R.L., PLATIKA, D., SHORT, M.P., MALIK, A., CHOI, B., and BREAKEFIELD, X.O. (1991). Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. The New Biol. 3, 608-614.
15. FURMAN, P.A., McGUIRT, P.V., KELLER, P.M., FYFE, J.A., and ELION, G.B. (1980). Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information. Virology 102, 420-430.
16. GARVER, R.I., GOLDSMITH, K.T., RODU, B., HU, P-C., SORSCHER, E.J., and CURIEL, D.T. (1994). Strategy for achieving selective killing of carcinomas. Gene Ther. 1, 46-50.
17. GRIFFITH, D.A., and JARVIS, S.M. (1993). High affinity sodium-dependent nucleobase transport in cultured renal epithelial cells (LLC-PK). J. Biol. Chem. 268, 20085-20090.
18. GUTIERREZ, A.A., LEMODiE, N.R., and SIKORA, K. (1992). Gene therapy for cancer. The Lancet. 339, 715-721.
19. HARRIS, J.D., GUTIERREZ, A.A., HURST, H.C., SIKORA, K., and LEMOINE, N.R. (1994). Gene therapy for cancer using tumor-specific prodrug activation. Gene Ther. 1, 170-175.
20. HERSH, J., CRYSTAL, R.G., and BEWIG, B.B. (1995). Modulation of gene expression after replication deficient recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2, 124-131.
21. HERZ, J., and GERARD, R.D. (1993). Adenovirus-mediated transfer of the low density lipoprotein receptor gene accutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA 90, 2812-2816.
22. HEYMAN, R.A., BORRELLI, E., LESLEY, J., ANDERSON, D., RICHMAN, D.D., BAIRD, S.M., HYMAN, R., and EVANS, R. (1989). Thymidine kinase obliteration; creation of transgenic mice with controlled immune deficiency. Proc. Natl. Acad. Sci. USA 86, 2698-2702.
23. HUBER, B.E., RICHARDS, C.A., and KRENITSKY, T.A. (1991). Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc. Natl. Acad. Sci. USA 88, 8039-8043.
24. HUBER, B.E., AUSTIN, E.A., GOOD, S.S., KNICK, V.C., TIBBELS, S., and RICHARDS, C.A. (1993). In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53, 4619-4626.
25. HUBER, B.E., AUSTIN, E.A., RICHARDS, C.A., DAVIS, S.T., and GOOD, S.S. (1994). Metabolism of 5-fluorocytosine to 5-fluo-rouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of mmor cells express cytosinc deaminase. Proc. Natl. Acad. Sci. USA 91, 8302-8306.
26. JAFFE, H.A., DANEL, C., LONGENECKER, G., METZGER, M., SE-TOGUCHI, Y., ROSENFELD, M.A., GANT, T.W., THORGEIRS-SON, S.S., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J-P., and CRYSTAL, R.G. (1992). Adenovirus-mediated in vivo gene transfer and expression in normal rat hver. Nature Genet. 1, 372-378.
27. KILSTRUP, M., MENG, L.M., NEUHARD, J., and NYGAARD, P. (1989). Genetic evidence for a repressor of synthesis of cytosine deaminase and purine biosynthesis enzymes in Escheria coli. J. Bacteriol. 171, 2124-2127.
28. KORST, R., BEWIG, B., and CRYSTAL, R.G. (1995). In vivo and in vitro transfer and expression of human surfactant SP-A and SP-B associated protein cDNAs mediated by replication deficient, recombinant adenovirus vectors. Hum. Gene Ther. 6, 277-287.
29. LESALLE, G.L.G., ROBERT, J.J., BERRARD, S., RIDOUX, V., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., and MALLET, J. (1993). An adenovirus vector for transfer into neurons and glia in the brain. Science 259, 988-990.
30. MASTRANGELI, A., DANEL, C., ROSENFELD, M.A., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., PAVIRANI, J., LECOCQ, J.P., and CRYSTAL, R.G. (1993a). Diversity of the airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91, 225-234.
31. MASTRANGELI, A., O'CONNELL, B., ALADIB, W., FOX, P.C., BAUM, B.I., and CRYSTAL, R.G. (1993b). Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am. I. Physiol. 266, 1146-1155.
32. McGRORY, W.J., BAUTISTA, D.S., and GRAHAM, F.L. (1988). A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163, 614-617.
33. MOOLTEN, F.L. (1986). Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: a paradigm for a prospective cancer control strategy. Cancer Res. 46, 5276-5281.
34. MOOLTEN, F.L. (1994). Drug sensitivity (“suicide”) genes for selective cancer chemotherapy. Cancer Gene Ther. 1, 279-287.
35. MOOLTEN, F.L., WELLS, J.M., HEYMAN, R.A., and EVANS, R.M. (1990a). Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther. 1, 125-134.
36. MOOLTEN, F.L., and WELLS, I.M. (1990b). Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. I. Natl. Cancer Inst. 82, 297-300.
37. MORRIS, B.D., DRAZAN, K.E., CSETE, M.E., WERTHMAN, P.E., VAN BREE, M.P., ROSENTHAL, I.T., and SHARED, A. (1994). Adenoviral mediated gene transfer to bladder in vivo. J. Urol. 152, 506-509.
38. MORSY, M.A., ALFORD, E.L., BETT, A., GRAHAM, F.L., and CASKEY, C.T. (1993). Efficient adenoviral-mediated ornithine trans-carbamylase expression in deficient mouse human hepatocytes. J. Clin. Invest. 92, 1580-1586.
39. MOULLIER, P., FRIEDLANDER, G., CALISE, D., RONCO, P., PERRICAUDET, M., and FERRY, N. (1994). Adenoviral-mediated-gene transfer to renal tubular cells in vivo. Kidney Int. 45, 1220-1225.
40. MULLEN, C.A., KILSTRUP, M., and BLAESE, R.M. (1992). Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc. Natl. Acad. Sci. USA 89, 33-37.
41. MULLEN, C.A., COALE, M.M., LOWE, R., and BLAESE, M.R. (1994). Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res. 54, 1503-1506.
42. PLAUTZ, G., NABEL, E.G., and NABEL, G.I. (1991). Selective elimination of recombinant genes in vivo with a suicide retroviral vector. The New Biol. 3, 709-715.
43. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PER-RICAUDET, L.D., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOCQ J-P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cyctic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
44. STRATFORD-PERRICAUDET, L.D., LEVRERO, M., CHASSE, I-F., PERRICAUDET, M., and BRIAND, P. (1990). Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1, 241-256.
45. YANG, Y., RAPER, S.E., COHN, J.A., ENGELHARD!, I.E., WILSON, I.F., and WILSON, I.M. (1993). An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc. Natl. Acad. Sci. USA 90, 4601-4605.